Regenerative Medical Technology Group Inc. (ticker: RMTG) is an OTC-listed retail company. DredgeCap's structured extraction of RMTG's SEC filings surfaces 20 active risk signals, including 19 late-filing signals, and 1 auditor-change signal. RMTG reported $5.10M in revenue and -$7.81M for the period ending 2025-12-31, with operating cash flow of -$707K. Cash and equivalents stood at $957K (down 17.9% year-over-year). Total assets of $4.49M are exceeded by total liabilities of $39.23M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
RMTG Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for Regenerative Medical Technology Group Inc. (RMTG) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.